Heart drug may influence lung cancer treatment outcomes
NCT ID NCT05387512
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 25 times
Summary
This study looked back at the medical records of 60 people with advanced lung cancer to see if taking a common heart medication (beta-blockers) alongside immunotherapy affected their treatment results. Researchers compared how long the cancer was controlled and survival rates between those who took beta-blockers and those who did not. The goal was to gather information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Pharmacy, Affiliated Hospital of Nantong University
Nantong, Jiangsu, 226000, China
Conditions
Explore the condition pages connected to this study.